Primary Renal Neuroendocrine Tumor: Diagnostic Challenges in a Rare Entity—A Case Report
Current Oncology · 06.02.2026 · 33 (2) · 105
DOI: 10.3390/curroncol33020105 ↗Kurz gefasst
Fallbericht in der Zeitschrift Current Oncology, online erschienen am 06.02.2026. Verfasst von Raphaela D Lewetag und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tuebingen, 72076 Tuebingen, Germany. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Kidney Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy-EXC 2180-390900677, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Neuroendocrine neoplasms (NENs) represent a rare, heterogeneous group of malignancies. Within this tumor entity, primary renal neuroendocrine tumors (PRNETs) are exceedingly rare, with only 160 cases reported worldwide. Due to the absence of native neuroendocrine cells in the renal parenchyma, their cellular origin remains unclear. Clinical and diagnostic challenges are reflected by the low incidence, non-specific clinical presentation, resemblance to common renal neoplasms, and the need for specialized histopathological diagnostic examination. Here, we present the case of a 61-year-old female with an incidentally diagnosed left-sided PRNET in September 2024. This case highlights the diagnostic complexity of PRNET and, importantly, underscores its genomic heterogeneity. It demonstrates a lack of typical renal cell carcinoma (RCC) or common NEN-associated gene alterations, emphasizing their unique molecular landscape.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tuebingen, 72076 Tuebingen, Germany.
- ENETS Center of Excellence, University Hospital Tuebingen, 72076 Tuebingen, Germany.
- Department of Pathology, University Hospital Tuebingen, 72076 Tuebingen, Germany.
- Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tuebingen, 72076 Tuebingen, Germany.
- DFG Cluster of Excellence 2180 'Image-Guided and Functional Instructed Tumor Therapy', University of Tuebingen, 72076 Tuebingen, Germany.
- German Cancer Consortium, German Cancer Research Center, 72070 Tuebingen, Germany.
ORCID-Profile: Raphaela D Lewetag, Nils F Trautwein, Ulrich M Lauer, Christian la Fougère, Martina Hinterleitner
Förderung
- NCI NIH HHS
- Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy-EXC 2180-390900677
- Deutsche Forschungsgemeinschaft
- University of Tübingen
Zitieren
APA
Lewetag, R. D., Kluthe, K., Trautwein, N. F., Lauer, U. M., la Fougère, C., Sipos, B., Zender, L., Hinterleitner, C., Singer, S., & Hinterleitner, M. (2026). Primary Renal Neuroendocrine Tumor: Diagnostic Challenges in a Rare Entity—A Case Report. Current Oncology, 33(2), 105. https://doi.org/10.3390/curroncol33020105
Vancouver
Lewetag RD, Kluthe K, Trautwein NF, Lauer UM, la Fougère C, Sipos B, et al. Primary Renal Neuroendocrine Tumor: Diagnostic Challenges in a Rare Entity—A Case Report. Current Oncology. 2026;33(2):105. doi:10.3390/curroncol33020105
BibTeX
@article{Lewetag2026,
author = {Lewetag, Raphaela D and Kluthe, Katharina and Trautwein, Nils F and Lauer, Ulrich M and la Fougère, Christian and Sipos, Bence and Zender, Lars and Hinterleitner, Clemens and Singer, Stephan and Hinterleitner, Martina},
title = {Primary Renal Neuroendocrine Tumor: Diagnostic Challenges in a Rare Entity—A Case Report},
journal = {Current Oncology},
year = {2026},
volume = {33},
number = {2},
pages = {105},
doi = {10.3390/curroncol33020105}
}
EUVIMED